Stem Cell Human Trials for Macular Degene... - Cure Parkinson's

Cure Parkinson's

26,582 members27,897 posts

Stem Cell Human Trials for Macular Degeneration

jimcaster profile image
6 Replies

We aren't there yet with Parkinson's Disease, but I still remain excited about the possibility of turning back time with stem cells. Even if the disease continues to progress, we may be able to refill our tanks with dopaminergic neurons.

"Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration (AMD), a leading cause of vision loss among people age 65 and older. The geographic atrophy form of AMD currently has no treatment."

nih.gov/news-events/news-re...

Written by
jimcaster profile image
jimcaster
To view profiles and participate in discussions please or .
Read more about...
6 Replies
chartist profile image
chartist

In the meantime, Amla may be able to help with Macular Degeneration among many other health issues!

ncbi.nlm.nih.gov/pmc/articl...

Art

park_bear profile image
park_bear in reply tochartist

Art - do you have any references showing Amla efficacy in Parkinson's? - Thanks!

chartist profile image
chartist in reply topark_bear

Sorry, park_bear,

I never found any studies directly related to PD. About all you can do is just take the positives from the human studies and apply those benefits to humans in general. Amla is an IL-8 inhibitor, but I found nothing which showed if it crosses the BBB. The main points of amla is that it is very good for overall health because of its cholesterol lowering activity, triglyceride lowering activity, very potent antioxidant activity on its own plus its ability to dramatically increase glutathione (> 53% in 12 weeks) plus catalase and super oxide dismutase and then add in its potent antiinflammatory activity where it lowers multiple inflammatory mediators (tnf-alpha and il-6) that are known to be active in PD and other diseases and its ability to lower malondialdehyde which is used as a marker of oxidative stress. It effectively lowered high sensitivity C-reactive protein (hsCRP) over 53% in twelve weeks. It also significantly lowered the atherosclerotic index which is very important for the heart and longevity. It also is considered to be a very good supplement to be taken after or before a stroke.

I may have missed a point or two, but those were the highlights as I remember them off of the top of my head.

Art

sharoncrayn profile image
sharoncrayn in reply tochartist

I seriously doubt that Amla would inhibit IL-6 or IL-8 (both are somewhat similar in construct) to any significant degree. Nor do I find any rationale of significance in the human research literature to believe any supplement would (or should) inhibit these or any of the other chemokines in a major way.

I realize that this statement contradicts some comments previously made on this subject on this forum about certain supplements inhibiting IL-8. Frankly, significantly inhibiting or modifying this chemokine would or could potentially become life threatening. Playing around with altering their relationship with associated neutrophils is akin to playing with dynamite.

Theoretical constructs in cell biology are interesting and provocative for those few who actually understand them, but seldom translate into the real world for a very good reason.

Sharon

WinnieThePoo profile image
WinnieThePoo

I agree that progress in stem cell research generally is hopeful for PD. I wonder why they use blood cells when PD research seems to use skin cells

jimcaster profile image
jimcaster in reply toWinnieThePoo

Good question regarding blood cells vs. skin cells. I just know Dr. Loring seems very confident. I wish her human trials were underway,

Not what you're looking for?

You may also like...

Stem Cells Trials

I want to make a list here. Please reply with links...

Aspen FINALLY Moving forward with Stem Cell Trials

I have been repeatedly writing posts regarding Dr. Jeanne Loring, Aspen Neuroscience, and/or stem...
jimcaster profile image

Phase 2 Mesenchymal Stem Cell Trial in USA

"A newly opened Phase 2 clinical trial is evaluating adult stem cells as a potentially...
jimcaster profile image

More Stem Cell Success!

A new therapeutic approach in which patient-derived dopamine-producing neurons are transplanted...
jimcaster profile image

Stem Cell Success With MS

One of many reasons I'm excited about stem cell therapy for those of us with Parkinson's is because...
jimcaster profile image